47.90
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Pulse Biosciences: Promising Technology, But Hard To Justify Its Valuation (NASDAQ:PLSE) - Seeking Alpha
Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily
Pulse Biosciences stock reports 100 patient trial milestone - AD HOC NEWS
TriSalus Life Sciences, Lakefront Biotherapeutics, Editas Medicine And Other Big Stocks Moving Higher On Wednesday - benzinga.com
BTIG initiates Pulse Biosciences stock coverage with buy rating By Investing.com - Investing.com Australia
BTIG Initiates Pulse Biosciences at Buy With $70 Price Target - Yahoo Finance
BTIG Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $70 - Moomoo
BTIG initiates coverage of Pulse Biosciences with Buy rating, $70 price target - TradingView
PLSE Initiated by BTIG -- Price Target Set at $70.00 - GuruFocus
Is Pulse Biosciences (PLSE) Fully Valued As Its Thyroid Trial Reaches 100 Patients? - Simply Wall Street
Pulse Biosciences, Inc (PLSE) Stock Analysis: A Healthcare Innovator with Strong Buy Ratings Amidst Volatile Market Conditions - DirectorsTalk Interviews
Pulse Biosciences Launches New ATM Equity Program - theglobeandmail.com
Pulse Biosciences (NASDAQ: PLSE) Launches $85M ATM Offering at $54.21 Per Share - Kalkine Media
Form 8K Pulse Biosciences Inc For: 15 September By Investing.com - Investing.com Australia
Pulse Biosciences Opens New $85 Million At-the-Market Stock Offering - Minichart
Pulse Biosciences enters $85 million equity distribution agreement with Mizuho - Investing.com
Pulse Biosciences completes enrollment in thyroid nodule study By Investing.com - Investing.com Nigeria
Pulse Biosciences Finalizes Enrollment for PRECISE-BTN Trial Evaluating nPulse Vybrance System - Kalkine Media
Pulse Biosciences Completes Enrollment In The PRECISE-BTN Clinical Study Evaluating The nPulse Vybrance Percutaneous Electrode System For Symptomatic Benign Thyroid Nodules - marketscreener.com
Pulse Biosciences (PLSE) Advances PRECISE-BTN Trial as Valuation Reflects High Growth Expectations - GuruFocus
Pulse Biosciences completes enrollment in thyroid nodule study - Investing.com
Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules - Business Wire
Why is Pulse Biosciences stock surging today? By Investing.com - Investing.com Nigeria
Pulse Biosciences stock hits all-time high at 56.15 USD By Investing.com - Investing.com Nigeria
Freedom Capital initiates Pulse Biosciences stock with buy rating By Investing.com - Investing.com Australia
Why Pulse Biosciences Stock Popped Today - theglobeandmail.com
Freedom Capital Markets Initiates Pulse Biosciences(PLSE.US) With Buy Rating, Announces Target Price $73 - Moomoo
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Pulse Biosciences stock hits all-time high at 56.15 USD - Investing.com India
$Pulse Biosciences (PLSE.US)$ the squeeze is onnnnnnnn - Moomoo
PLSE Initiates Coverage by Freedom Capital Markets -- Price Targ - GuruFocus
Freedom Capital initiates Pulse Biosciences stock with buy rating - investing.com
PLSE Q2 2026 Earnings: Narrower-Than-Expected Loss Yields 1.96% Surprise But Shares DeclineEPS Miss Report - careplusvn.com
(PLSE) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Pulse Biosciences Stock Price Forecast. Should You Buy PLSE? - StockInvest.us
Pulse Biosciences stock holds steady as investors eye recent clinical and financial progress - AD HOC NEWS
Pulse Biosciences (PLSE) Grants Equity Awards to New Hires Amid High Price-to-Sales Valuation - GuruFocus
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Pulse Biosciences Inc (DE) (PLSE) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock By Investing.com - Investing.com Australia
Pulse Biosciences COO Liane Teplitsky buys $99,971 in stock - Investing.com India
COO pays nearly $50 a share for Pulse Biosciences (NASDAQ: PLSE) - Stock Titan
Pulse Biosciences Inc (DE) (PLSE) Peer Comparison – Compare with Others - Value Research
$Pulse Biosciences (PLSE.US)$ New ATH 🔥 - Moomoo
Pulse Biosciences Reports Teplitsky Liane Rae as New Insider COO - Kalkine Media
Pulse Biosciences stock hits new high as insider buying fuels rally - AD HOC NEWS
Pulse Biosciences stock hits all-time high at 51.0 USD - Investing.com
Pulse Biosciences stock hits all-time high at 51.0 USD By Investing.com - Investing.com Canada
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):